11 December 2017

Amedeo Smart

Independent Medical Education

Subscriber: th..@boehringer-ingelheim.com

HIV Infection

11 December 2017 | n=34

  1. Bernardes C, Russo P, Carvalho D, Saiote J, et al.
    Primary HIV infection in a Crohn's disease patient receiving infliximab maintenance therapy.
    AIDS 2018;32:130-131.

  2. Yoshimura Y, Miyata N, Komatsu H, Tachikawa N, et al.
    Remarkable plasma HIV RNA decrease by ombitasvir/paritaprevir/ritonavir in an HIV-HCV coinfection case.
    AIDS 2018;32:128-129.

  3. Cattaneo D, Rizzardini G, Gervasoni C.
    Psychoactive drugs and HIV: are we sure to treat our patients adequately?
    AIDS 2018;32:127-128.

  4. Durand-Zaleski I, Mutuon P, Charreau I, Tremblay C, et al.
    Costs and benefits of on-demand HIV preexposure prophylaxis in MSM.
    AIDS 2018;32:95-102.

  5. Novitsky V, Prague M, Moyo S, Gaolathe T, et al.
    High HIV-1 RNA among Newly Diagnosed People in Botswana.
    AIDS Res Hum Retroviruses 2017.

  6. Sylla LN, Evans D, Taylor J, Gilbertson AL, et al.
    If We Build It, Will They Come? Perceptions of HIV Cure-Related Research by People Living with HIV in Four U.S. Cities - A Qualitative Focus Group Study.
    AIDS Res Hum Retroviruses 2017.

  7. Ma Y, Dou Z, Guo W, Mao Y, et al.
    The Human Immunodeficiency Virus Care Continuum in China: 1985-2015.
    Clin Infect Dis 2017.

  8. Rouet F, Nouhin J, Zheng DP, Roche B, et al.
    Massive Iatrogenic Outbreak of Human Immunodeficiency Virus Type 1 in Rural Cambodia, 2014-2015.
    Clin Infect Dis 2017.

  9. Novelli S, Lecuroux C, Avettand-Fenoel V, Seng R, et al.
    Long-term therapeutic impact of the timing of ART in patients diagnosed with primary HIV-1 infection.
    Clin Infect Dis 2017.

  10. Glesby MJ, Hanna DB, Hoover DR, Shi Q, et al.
    Abdominal Fat Depots and Subclinical Carotid Artery Atherosclerosis in Women with and without HIV Infection.
    J Acquir Immune Defic Syndr 2017.

  11. van Epps P, Maier M, Lund B, Howren MB, et al.
    "Medication Adherence in a Nationwide Cohort of Veterans Initiating Pre-Exposure Prophylaxis (PrEP) to Prevent HIV Infection".
    J Acquir Immune Defic Syndr 2017.

  12. Newcomb ME, Moran K, Feinstein BA, Forscher E, et al.
    Pre-Exposure Prophylaxis (PrEP) Use and Condomless Anal Sex: Evidence of Risk Compensation in a Cohort of Young Men Who Have Sex with Men.
    J Acquir Immune Defic Syndr 2017.

  13. Calkins KL, Lesko CR, Chander G, Moore RD, et al.
    Influence of Injection Drug Use-Related HIV Acquisition on CD4 Response to First Antiretroviral Therapy Regimen among Virally Suppressed Individuals.
    J Acquir Immune Defic Syndr 2017.

  14. Familiar I, Collins SM, Sikorskii A, Ruisenor-Escudero H, et al.
    Quality of caregiving is positively associated with neurodevelopment during the first year of life among HIV-exposed uninfected children in Uganda.
    J Acquir Immune Defic Syndr 2017.

  15. Flash CA, Adegboyega OO, Yu X, Avalos C, et al.
    Correlates of Linkage to HIV Pre-exposure Prophylaxis (PrEP) among HIV Testing Clients.
    J Acquir Immune Defic Syndr 2017.

  16. LaFleur J, Bress AP, Esker S, Knippenberg K, et al.
    Tenofovir-Associated Nephrotoxicity Among a US National Historical Cohort of HIV-Infected Veterans: Risk Modification by Concomitant Antiretrovirals.
    J Acquir Immune Defic Syndr 2017.

  17. Lippman SA, Lane T, Rabede O, Gilmore H, et al.
    High Acceptability and Increased HIV Testing Frequency Following Introduction of HIV Self-Testing and Network Distribution among South African MSM.
    J Acquir Immune Defic Syndr 2017.

  18. Rohr JK, Ive P, Horsburgh CR, Berhanu R, et al.
    Assessing the association between changing NRTIs when initiating second-line ART and treatment outcomes.
    J Acquir Immune Defic Syndr 2017.

  19. Urick B, Fong Y, Okiira C, Nabukeera-Barungi N, et al.
    Rapid Serological Tests Ineffectively Screen for Hiv Exposure in Hiv-Positive Infants.
    J Acquir Immune Defic Syndr 2017.

  20. Lataillade M, Zhou N, Joshi SR, Lee S, et al.
    Viral Drug Resistance through 48 Weeks, in a Phase 2b, Randomized, Controlled Trial of the HIV-1 Attachment Inhibitor Prodrug, Fostemsavir.
    J Acquir Immune Defic Syndr 2017.

  21. Wood D, Lancaster KE, Boily MC, Powers KA, et al.
    Recruitment of Female Sex Workers in HIV Prevention Trials: Can Efficacy Endpoints Be Reached More Efficiently?
    J Acquir Immune Defic Syndr 2017.

  22. Nyitray AG, Fujimoto K, Zhao J, Giuliano AR, et al.
    Prevalence of and risk factors for anal HPV among a sample of predominantly black men who have sex with men in Houston, Texas.
    J Infect Dis 2017.

  23. Patel P, Bush T, Kojic EM, Conley L, et al.
    Prevalence, incidence, and clearance of anal high-risk human papillomavirus (HPV) infection among HIV-infected men in the SUN Study.
    J Infect Dis 2017.

  24. Stella-Ascariz N, Arribas JR, Paredes R, Li JZ, et al.
    The Role of HIV-1 Drug-Resistant Minority Variants in Treatment Failure.
    J Infect Dis 2017;216:S847-S850.

  25. Wallis CL, Godfrey C, Fitzgibbon JE, Mellors JW, et al.
    Key Factors Influencing the Emergence of Human Immunodeficiency Virus Drug Resistance in Low- and Middle-Income Countries.
    J Infect Dis 2017;216:S851-S856.

  26. Raizes E, Hader S, Birx D.
    Expansion of Viral Load Testing and the Potential Impact on HIV Drug Resistance.
    J Infect Dis 2017;216:S805-S807.

  27. Makvandi-Nejad S, Laurenson-Schafer H, Wang L, Wellington D, et al.
    Lack of Truncated IFITM3 Transcripts in Cells Homozygous for the rs12252-C Variant That is Associated With Severe Influenza Infection.
    J Infect Dis 2017.

  28. Pernas M, Tarancon-Diez L, Rodriguez-Gallego E, Gomez J, et al.
    Factors Leading to the Loss of Natural Elite Control of HIV-1 Infection.
    J Virol 2017.

  29. Kirschman J, Qi M, Ding L, Hammonds J, et al.
    HIV-1 Envelope Glycoprotein Trafficking through the Endosomal Recycling Compartment is Required for Particle Incorporation.
    J Virol 2017.

  30. Sato K, Misawa N, Takeuchi JS, Kobayashi T, et al.
    Experimental adaptive evolution of SIVcpz to pandemic HIV-1 using a humanized mouse model.
    J Virol 2017.

  31. Sevinsky H, Zaru L, Wang R, Xu X, et al.
    Pharmacokinetics and Pharmacodynamics of Atazanavir in HIV-1-Infected Children Treated With Atazanavir Powder and Ritonavir: Combined Analysis of the PRINCE-1 and -2 Studies.
    Pediatr Infect Dis J 2017.

  32. Cotton MF, Liberty A, Torres-Escobar I, Gonzalez-Tome MI, et al.
    Safety and Efficacy of Atazanavir Powder and Ritonavir in HIV-1-Infected Infants and Children Aged From 3 Months to <11 Years: the PRINCE-2 Study.
    Pediatr Infect Dis J 2017.

  33. Paul R, Prasitsuebsai W, Jahanashad N, Puthanakit T, et al.
    Structural Neuroimaging and Neuropsychologic Signatures of Vertically Acquired HIV.
    Pediatr Infect Dis J 2017.

  34. Siberry GK.
    Beyond Prevention of Vertical HIV Transmission - Improving Outcomes of HIV-Uninfected Infants Born to Mothers with HIV Infection.
    Pediatr Infect Dis J 2017.

Display articles in

Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:

Amedeo HIV Infection

Five-Week Literature

21 January 2019

14 January 2019

07 January 2019

30 December 2018

23 December 2018

11 December 2017

Multidisciplinary Journal Club

  1. Torres VE, Chapman AB, Devuyst O, Gansevoort RT, et al.
    Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease.
    N Engl J Med. 2017;377:1930-1942.

  2. Gilbert DN, Kalil AC, Klompas M, Masur H, et al.
    IDSA POSITION STATEMENT: Why IDSA Did Not Endorse the Surviving Sepsis Campaign Guidelines.
    Clin Infect Dis. 2017 Nov 22. pii: 4645414. doi: 10.1093.

  3. Grabowski MK, Serwadda DM, Gray RH, Nakigozi G, et al.
    HIV Prevention Efforts and Incidence of HIV in Uganda.
    N Engl J Med. 2017;377:2154-2166.

Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016